Upgrade to SI Premium - Free Trial

Audentes Therapeutics (BOLD) PT Lowered to $41 at Piper Jaffray

November 7, 2018 4:34 AM
Piper Jaffray analyst Christopher Raymond ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change